基于表位屏蔽理论的Co-60辐照结合糖基化降低OVA致敏性的分子机制
批准号:
32060525
项目类别:
地区科学基金项目
资助金额:
35.0 万元
负责人:
刘光宪
依托单位:
学科分类:
食品生物化学
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
刘光宪
中文摘要
前期研究表明,辐照可以促进卵清蛋白(OVA)内部氨基酸的糖基化进而降低其致敏性,这与其过敏表位的屏蔽密切相关。为了探清其内在机制,以OVA和还原糖为研究对象,经Co-60辐照结合糖基化处理,采用食品分析、ELISA、免疫印迹和细胞学等方法分析其糖基化和致敏性的变化规律,制备低敏性OVA;运用质谱、光谱和同位素标记等方法研究其一级和高级结构的变化;通过氧-18标记、Orbitrap MS等技术对糖基化位点进行定性定量分析;借助抗体捕获OVA中的主要过敏组分,采用质谱、nano光谱、HDX等方法表征其结构和抗原结合位点。并与天然OVA对比,解析辐照条件-糖基化位点/程度-致敏性-过敏表位之间的相关性,从已知过敏表位、糖基化屏蔽位点/屏蔽程度和抗原结合位点三个角度揭示Co-60辐照结合糖基化降低OVA致敏性的分子机制,从而完善糖基化蛋白质的表位屏蔽理论,为新型脱敏技术的研发提供理论指导。
英文摘要
Our previous research showed that irradiation could promote the glycation of ovalbumin (OVA) and reduced its allergenicity, which was closely related to the shielding of glyation sites on allergic epitopes. In order explore its internal mechamism, OVA and reducing sugar were used as research objects to treat by Co-60 irradiation. The change of glycation and allergenicity were analyzed by the technology such as food analysis, ELISA, western blot and cytology, and obtained the hypoallergenic OVA sample. The changes of their primary and higher structures were studied by mass spectrometry, spectrum and isotope labeling methods. The glycation sites were qualitatively and quantitatively analyzed by oxygen-18 labeling and Orbitrap MS and other methods. The main allergic components in OVA were captured by antibodies, and their structures and antigen binding sites were characterized by mass spectrometry, nano-spectroscopy and HDX. The correlation among the changes of irradiation conditions-glycation sites/degree – allergenicity - allergic epitopes was analyzed. By comparing with natural OVA, the molecular mechanism of reducing OVA allergenicity by Co-60 irradiation combined with glycation was revealed from three aspects including in known allergic epitopes, glycation shielding sites/extent of shielding and antigen binding sites, so as to improve the protein glycation table of shielding theory, provide theoretical guidance for the development of new desensitization technology.
鸡蛋蛋白是人们日常饮食中一种高质低价的蛋白质,其不但含有人体必需的八种必需氨基酸和婴幼儿时期人体不能自身合成的组氨酸,且各氨基酸比例较适合人体生理需要、易为机体吸收,利用率高达98%以上。但鸡蛋蛋白也是食物过敏的主要过敏原蛋白,鸡蛋过敏不仅给过敏患者造成了极大的身心痛苦,也给食品加工业带来了众多安全隐患,因此,降低或消除鸡蛋蛋白的致敏性对于保障大众饮食安全十分必要。本研究前期发现OVA经Co-60辐照结合糖基化处理后,OVA致敏性得到降低,但其机制不清楚。本项目以OVA和还原糖为对象,在Co-60辐照条件下进行糖基化修饰,研究了辐照处理后OVA的糖基化和致敏性变化规律,制备低敏性OVA;研究了其高级构象和一级结构的变化规律,并对其糖基化位点进行定性定量分析;借助抗体捕获OVA中的主要过敏组分,并对其结构和抗原结合位点进行表征。通过与天然OVA对比分析,解析了辐照条件-糖基化位点/程度-致敏性-过敏表位之间的相关性,揭示了Co-60辐照结合糖基化降低OVA致敏性的分子机制。其机制如下:一是Co-60辐照产生的电子束具有较强的穿透力,随着辐照剂量的增加,OVA蛋白发生显著的去折叠现象,构象结构发生变化,蛋白质的肽键在不同程度上发生破坏、氨基酸被修饰,导致OVA与IgG和IgE的结合减弱,一定程度上降低了致敏性。另外,一些过敏位点暴露出来,增加了其与还原糖结合的几率,为蛋白质糖基化降低致敏性提供了可能。二是Co-60辐照促进了OVA和还原糖发生化学反应,暴露的五个关键IgE线性结合表位AA38-49、AA95-102、AA191-200、AA243-248和AA251-260与还原糖结合发生糖基化修饰,进而降低致敏性。项目研究完善糖基化蛋白质的表位屏蔽理论,为新型脱敏技术的研发提供理论指导。
国内基金
海外基金